These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 34512381)

  • 1. Is Oxidative Stress the Link Between Cerebral Small Vessel Disease, Sleep Disruption, and Oligodendrocyte Dysfunction in the Onset of Alzheimer's Disease?
    Lloret A; Esteve D; Lloret MA; Monllor P; López B; León JL; Cervera-Ferri A
    Front Physiol; 2021; 12():708061. PubMed ID: 34512381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep as a Novel Biomarker and a Promising Therapeutic Target for Cerebral Small Vessel Disease: A Review Focusing on Alzheimer's Disease and the Blood-Brain Barrier.
    Semyachkina-Glushkovskaya O; Postnov D; Penzel T; Kurths J
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-Associated Oligodendrocyte: New Player in Alzheimer's Disease and CNS Pathologies.
    Chen P; Guo Z; Zhou B
    J Integr Neurosci; 2023 Jul; 22(4):90. PubMed ID: 37519162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligodendrocytes and Alzheimer's disease.
    Cai Z; Xiao M
    Int J Neurosci; 2016; 126(2):97-104. PubMed ID: 26000818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
    Daulatzai MA
    J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Sleep Disruption a Risk Factor for Alzheimer's Disease?
    Macedo AC; Balouch S; Tabet N
    J Alzheimers Dis; 2017; 58(4):993-1002. PubMed ID: 28550253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
    Butterfield DA
    Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between age, cerebral small vessel disease, parenchymal amyloid-β, and tau pathology: longitudinal studies in hypertensive stroke-prone rats.
    Schreiber S; Drukarch B; Garz C; Niklass S; Stanaszek L; Kropf S; Bueche C; Held F; Vielhaber S; Attems J; Reymann KG; Heinze HJ; Carare RO; Wilhelmus MM
    J Alzheimers Dis; 2014; 42 Suppl 3():S205-15. PubMed ID: 24825568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non breathing-related sleep fragmentation and imaging markers in patients with atherosclerotic cerebral small vessel disease (CSVD): a cross-sectional case-control study.
    Wang J; Chen X; Liao J; Zhou L; Han H; Tao J; Lu Z
    BMC Neurol; 2020 Mar; 20(1):98. PubMed ID: 32183737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach.
    Calabrese V; Scapagnini G; Colombrita C; Ravagna A; Pennisi G; Giuffrida Stella AM; Galli F; Butterfield DA
    Amino Acids; 2003 Dec; 25(3-4):437-44. PubMed ID: 14661103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress in cerebral small vessel disease. Role of reactive species.
    Grochowski C; Litak J; Kamieniak P; Maciejewski R
    Free Radic Res; 2018 Jan; 52(1):1-13. PubMed ID: 29166803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease.
    Hamel E; Nicolakakis N; Aboulkassim T; Ongali B; Tong XK
    Exp Physiol; 2008 Jan; 93(1):116-20. PubMed ID: 17911359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian and sleep dysfunction in Alzheimer's disease.
    Uddin MS; Tewari D; Mamun AA; Kabir MT; Niaz K; Wahed MII; Barreto GE; Ashraf GM
    Ageing Res Rev; 2020 Jul; 60():101046. PubMed ID: 32171783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
    Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
    EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.
    Islam MT
    Neurol Res; 2017 Jan; 39(1):73-82. PubMed ID: 27809706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease.
    Volloch V; Olsen BR; Rits S
    Ann Integr Mol Med; 2019; 1(1):61-74. PubMed ID: 31858090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice.
    Han BH; Zhou ML; Johnson AW; Singh I; Liao F; Vellimana AK; Nelson JW; Milner E; Cirrito JR; Basak J; Yoo M; Dietrich HH; Holtzman DM; Zipfel GJ
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):E881-90. PubMed ID: 25675483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease.
    Calabrese V; Butterfield DA; Stella AM
    Ital J Biochem; 2003 Dec; 52(4):177-81. PubMed ID: 15141484
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.